SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending amid intense speculation of an improved acquisition offer from Sanofi, following a rejected $16/share bid. The community is highly optimistic about upcoming Phase 3 data for AXPAXLI in wet AMD, fueling expectations for a substantial premium or strong independent commercialization, a sentiment reinforced by a recent high-profile CCO hire.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token is trending as the community highlights recent tokenomics updates including token burns, product upgrades, and new exchange listings, fueling discussions about its low market cap and staking rewards driving potential growth within the AI crypto sector.

TOSHI

TOSHI is actively trending as the 'Face of Base,' with the community closely observing bullish chart patterns and anticipating a significant breakout, driven by increasing volume and broader market expectations for an altcoin season.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

The crypto community is intensely bullish on $SATOSHI, viewing it as the ultimate tokenization of the timeless Satoshi Nakamoto legacy and the identity of the entire industry. Widespread discussions center on its unparalleled cultural significance and potential to become a foundational blue-chip asset, offering a second chance at early Bitcoin-like gains as the "We are all Satoshi" movement gains global traction.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is generating significant buzz due to ongoing V4 developments, new partnerships, and its near-max token supply, igniting a heated debate among investors about an impending 'supply shock' versus concerns over governance stability and treasury health.

NextEra Energy, Inc. engages in the provision of renewable energy. It operates through the following segments: FPL and NEER. The FPL segment involves the generation, transmission, distribution, and sale of electric energy in Florida. The NEER segment produces electricity from clean and renewable sources, including wind and solar. The company was founded on December 28, 1925 and is headquartered in Juno Beach, FL.

NextEra Energy Inc

NextEra Energy is a major talking point as its strategic partnerships with tech giants like Google and Meta position it to meet the exploding power demands of AI data centers through expanded clean and nuclear energy initiatives, leading the community to discuss its significant growth potential and role within the evolving utilities sector.

Power Solutions International, Inc. engages in the design, manufacture, and trade of power systems and electrical power generation equipment. The firm provides integrated turnkey solutions to global original equipment manufacturers and end-user customers within the energy, industrial, and transportation end markets. The company was founded by Gary S. Winemaster, Kenneth J. Winemaster, and William Winemaster in February 1985 and is headquartered in Wood Dale, IL.

Power Solutions International Inc

Power Solutions International

Power Solutions International is trending due to record sales driven by increasing data center demand and recent analyst upgrades. The community is actively discussing the stock's pronounced volatility post-earnings, with many seeing buying opportunities while others express concern over insider selling and valuation in the essential AI power infrastructure sector.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu Crypto is trending with a highly engaged community actively building out a unique permissionless brand, showcasing real-world products and initiatives. Despite broader market weakness, the community's strong conviction and continuous development efforts are driving conversation and positioning KENDU as a standout long-term play.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is trending following impressive January sales results, particularly a significant surge in digital sales, which has led to multiple analyst upgrades and increased price targets. The community is actively discussing its premium valuation relative to its consistent performance as a defensive consumer staple, with many also anticipating a potential stock split.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending after delivering compelling Phase 2 data for its CAR-T therapy, NXC-201, in AL Amyloidosis, showcasing exceptional response rates and a favorable safety profile, which led to an oversubscribed institutional offering. The community is actively discussing its 'best-in-class' potential, FDA designations, and promising expansion into larger autoimmune indications, positioning IMMX as a strong buyout prospect with growing institutional confidence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Its products include Pritumumab, CLNH5, and MultiPharm. The company was founded by Mark C. Glassy on March 3, 2014 and is headquartered in North Palm Beach, FL.

Nascent Biotech Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

NBIO
Nascent Biotech Inc

Feed

News

Sentiment

Fundamentals

Info

Latest NBIO News

NBIONascent Biotech Inc